Javier S. Burgos

Javier S. Burgos

Auto-generated profile, based on publicly available information

Javier S. Burgos

Universitat Jaume I

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2011 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
SSSaleta Sierra
Saleta Sierra
MRMaría C. Ramos
María C. Ramos
PMPilar Molina
Pilar Molina
CECynthia Esteo
Cynthia Esteo
JVJose Antonio Vázquez
Jose Antonio Vázquez
JBJavier S. Burgos
Javier S. Burgos
There is growing evidence to support the hypothesis that statins may act as neuroprotectants in several neuropathological conditions, including Alzheimer's disease. The mechanisms for neuroprotection are only partially understood, however, and pleiot

1 June 2006 in Journal of Virology
Verified
Journal Article
Closed access
JBJavier S. Burgos
Javier S. Burgos
CRCarlos Ramirez
Carlos Ramirez
ISIsabel Sastre
Isabel Sastre
FVFernando Valdivieso
Fernando Valdivieso
Herpes simplex virus type 1 (HSV-1) is neurotropic and enters a latent state lasting the lifetime of the host. This pathogen has recently been proposed as a risk factor for Alzheimer's disease (AD) in conjunction with apolipoprotein E4 (ApoE4). In a murine acute infection model, we showed that viral neuroinvasiveness depends directly on the overall ApoE dosage and especially on the presence of isoform ApoE4. If an interaction between ApoE and HSV-1 is involved in AD, it may occur during latency rather than during acute infection. Certainly, ApoE plays an important role in late-onset AD, i.e., at a time in life when the majority of people harbor HSV-1 in their nervous system. In the present work, wild-type, APOE knockout, APOE3, and APOE4 transgenic mice were used to analyze the influence of the ApoE profile on the levels of latent virus DNA. The knockout mice had significantly lower concentrations of the virus in the nervous system than the wild-type mice, while the APOE4 mice had very high levels in the brain compared to the APOE3 animals. ApoE4 seems to facilitate HSV-1 latency in the brain much more so than ApoE3. The APOE dosage correlated directly with the HSV-1 DNA concentration in the brain, strengthening the hypothesis that HSV-1, together with ApoE, might be involved in AD.

1 January 2011 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
EBElena Bonzon-Kulichenko
Elena Bonzon-Kulichenko
DPDaniel Pérez-Hernández
Daniel Pérez-Hernández
ENEstefanía Núñez
Estefanía Núñez
PMPablo Martínez-Acedo
Pablo Martínez-Acedo
PNPedro Navarro
Pedro Navarro
JVJesus Vazquez
Jesus Vazquez
MS-based quantitative proteomics plays an increasingly important role in biological and medical research and the development of these techniques remains one of the most important challenges in mass spectrometry. Numerous stable isotope labeling approaches have been proposed. However, and particularly in the case of 18O-labeling, a standard protocol of general applicability is still lacking, and statistical issues associated to these methods remain to be investigated. In this work we present an improved high-throughput quantitative proteomics method based on whole proteome concentration by SDS-PAGE, optimized in-gel digestion, peptide 18O-labeling, and separation by off-gel isoelectric focusing followed by liquid chromatography-LIT-MS. We demonstrate that the off-gel technique is fully compatible with 18O peptide labeling in any pH range. A recently developed statistical model indicated that partial digestions and methionine oxidation do not alter protein quantification and that variances at the scan, peptide, and protein levels are stable and reproducible in a variety of proteomes of different origin. We have also analyzed the dynamic range of quantification and demonstrated the practical utility of the method by detecting expression changes in a model of activation of Jurkat T-cells. Our protocol provides a general approach to perform quantitative proteomics by 18O-labeling in high-throughput studies, with the added value that it has a validated statistical model for the null hypothesis. To the best of our knowledge, this is the first report where a general protocol for stable isotope labeling is tested in practice using a collection of samples and analyzed at this degree of statistical detail.

1 June 2003 in BioTechniques
Verified
Journal Article
Open access
JBJ.S. Burgos
J.S. Burgos
MRM. Rosol
M. Rosol
RMR.A. Moats
R.A. Moats
VKV. Khankaldyyan
V. Khankaldyyan
DKD.B. Kohn
D.B. Kohn
WLW.E. Laug
W.E. Laug
In vivo bioluminescence imaging is becoming increasingly popular. Quantification of bioluminescent signals requires knowledge of the variability and reproducibility of this technique. The objective...

1 September 2001 in Brain Research
Verified
Journal Article
Closed access
DLDiogo R Lara
Diogo R Lara
ASAndré P Schmidt
André P Schmidt
MFMarcos E.S Frizzo
Marcos E.S Frizzo
JBJavier S Burgos
Javier S Burgos
GRGalo Ramı́rez
Galo Ramı́rez
DSDiogo O Souza
Diogo O Souza

1 December 2008 in Zebrafish
Verified
Journal Article
Closed access
JBJavier S. Burgos
Javier S. Burgos
JRJorge Ripoll-Gomez
Jorge Ripoll-Gomez
JAJuan M. Alfaro
Juan M. Alfaro
ISIsabel Sastre
Isabel Sastre
FVFernando Valdivieso
Fernando Valdivieso
The zebrafish (Danio rerio) is rapidly gaining ground as a disease model. However, until now, the use of this species with human pathogens has been restricted to just three bacteria; no studies involving viruses that infect humans are recorded. In this study, the zebrafish was used as a model of herpes simplex virus type 1 (HSV-1) infection of the nervous system. Fish infected using viral culture supernatants showed detectable HSV-1 DNA concentrations 1–4 days after inoculation, indicating that this virus can experimentally infect and persist in this host. The kinetics of infection was dose dependent, especially in the head. Histological immunodetection of HSV-1 glycoproteins confirmed the presence of HSV-1 in the organs studied; infection led to histopathological changes. Moreover, the suppression of the immune system by cyclophosphamide and the antiviral effect of acyclovir were demonstrated. The infection of the encephalon was studied in detail, and the time course of viral colonization recorded. Immunofluorescence studies provided immunoreactive evidence of viral antigens in the encephalon and spinal cord. Viruses cleared from infected brains showed the ability to infect human neuroblastoma cells. This study is the first to demonstrate HSV-1 infection in the zebrafish and manifests the potential use of this species in herpesvirus studies.